Philadelphia’s life sciences sector saw major strides this week, from strong financial reports to groundbreaking research at The Wistar Institute. Key leadership moves signal continued growth and a reason for optimism. With funding wins, clinical breakthroughs, and executive shifts, Philly remains a powerhouse for biotech innovation. Read on for our top stories shaping the industry!
Kardigan: Acquires Prolaio to Create a Pioneering Heart Health Company With One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform More
Annovis Bio: Receives Continued Listing Standard Notice From the NYSE More
The Wistar Institute: Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology More
Traws Pharma: Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates More
Soligenix: Publication Demonstrating CiVax Booster Induces Rapid Broad Protection Against COVID-19 Variants More
Savara: Completes Submission of the Biologics License Application to the U.S. Food and Drug Administration for MOLBREEVI as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis More
Sonnet BioTherapeutics: Successfully Completes First Safety Review of SON-1010 in Combination With Trabectedin in Certain Sarcomas More
Teleflex: Preliminary Results From IDE Study on Ringer Perfusion Balloon Catheter Reported From Podium at CTO Plus Conference More
WORKFORCE
Harmony Biosciences: Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands More
Center for Forensic Science Research: Lays Off 30% of Staff Amid Federal Funding Uncertainty More
Verrica Pharmaceuticals: Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer More
Arbutus: Jettisoning 57% of Staff, Ceasing In-House Research More
JOBS
iECURE (Philadelphia, PA) – A clinical-stage gene editing company. Check out jobs here>
Director, Global Regulatory Affairs
Manager, Manufacturing (Upstream)
Manager, Manufacturing (Downstream)
Cabaletta Bio (Philadelphia, PA) – A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies. Check out jobs here>
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
